Insider buying last 90 days
No open-market insider purchases were filed for HLN in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every HLN insider filing, plotted on the chart in Gekko.Open HLN in Gekko
Haleon (HLN) Stock Analysis & Forecast
$9.28−0.08 (−0.9%)
Close on Sep 18, 2026. Page updated Sep 19, 9:16 pm ET.
Gekko Brief
AI summaryHaleon (HLN) closes at $9.28, down 0.9%, sitting below both its 50-day average of $9.81 and its 200-day average of $9.82, with the 50-day itself below the 200-day. The GekkoIndex reads 67.9, placing the stock in the Accumulation zone, down from a five-day change of -7.7. Against Gekko Fair Value of $13.37, the current price sits 30.6% below that level. Returns over one month stand at -6%, three months at 3.6%, six months at -9.3% and one year at -1.3%.
This week's coverage centers on Haleon's U.S. consumer health business, with reports that the Advil and TUMS maker has boosted American sales by targeting consumers on GLP-1 weight-loss drugs, positioning products in "GLP-1 destination sets" with retailers such as CVS Pharmacy to address common side-effects of those medications. Separately, commentary followed Haleon's interim dividend, payable 17 September 2026, framed around the company's approach to dividend growth since its 2022 demerger from GSK. Other pieces compared HLN's value against peer LCUT and flagged mixed near-term sentiment signals.
There is no confirmed next earnings date on the calendar; the last report, on 29 April 2026, showed an EPS actual of 0 against an estimate of $0.12, with a -2.4% reaction, and the company has beaten estimates in 3 of the last 8 quarters, with an average absolute reaction of 1.8%. Seasonality over the next 20 trading days has averaged +1.1% across 4 years, rising in 3 of them. Consensus from 1 firm carries a buy rating with a price target of $11.99, implying 29.2% upside from current levels. No insider, Congress or unusual options activity appears in the respective windows.
Written by AI and checked automatically against the figures on this page. Generated Sep 20, 2026 from the data above.
Price vs fair value
Close $9.28200-day averageGekko Fair Value $13.37
Key stats
- Market cap
- $40.87B
- P/E ratio
- 19.1
- Forward P/E
- 15.5
- EPS, TTM
- $0.49
- Revenue, TTM
- $11.15B
- Profit margin
- 14.5%
- Dividend yield
- 2.12%
- Beta
- 0.25
- Volume
- 45.17M avg 15.06M
- 1-year return
- −1.3%
- Typical daily move
- ±2.1%
- Typical 20-day move
- ±4.1%
- 50-day average
- $9.81
- 200-day average
- $9.82
- Next earnings
- —
- Shares outstanding
- 4.40B
Haleon swing-trade checklist
Haleon scores 3 supportive, 0 mixed and 1 headwind across the 4 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive0 mixed1 headwind
- Trendheadwind
Below 50 and 200-day
Close $9.28 is below the 50-day ($9.81) and 200-day ($9.82) averages, and the 50-day is below the 200-day.
See the chart - GekkoIndexsupportive
67.9, Accumulation
Reading 67.9 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
30.6% below
Price is 30.6% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskno data
No data
No confirmed report date on the calendar.
See earnings - Seasonalitysupportive
+1.1% on average
From this point in the calendar, the next 20 trading days averaged +1.1% over 4 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Haleon stock chart and price history
Haleon closed at $9.28 on Sep 18, 2026, −1.3% over the past year, inside a 52-week range of $8.65 to $11.28.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −6.0%
- 3 months
- +3.6%
- 6 months
- −9.3%
- 1 year
- −1.3%
The full HLN chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open HLN in Gekko
Follow Haleon through every session
Put HLN on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track HLN in GekkoFree for 7 days. No credit card required.
About Haleon
Haleon develops, manufactures, and distributes consumer wellness products, covering everything from early research through to getting finished goods onto shelves around the world. Its offerings span oral care, pain relief, respiratory support, and digestive health, along with vitamins, minerals, and other supplements. Among its recognizable names are Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum.
The business operates on an integrated model, running the full chain from scientific development to production and distribution rather than outsourcing these stages separately. Its goods reach consumers across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region, giving it a broad geographic footprint in the markets it serves.
Haleon traces its origins to 2021, when it was formed under the name DRVW 2022 plc before adopting its current name, Haleon plc, in February 2022. The company is headquartered in Brentford, in the United Kingdom, and its shares trade under the ticker HLN.
- Sector
- Health technology
- Website
- haleon.com
Haleon GekkoIndex: the smart money zone
Haleon’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 67.9, in the Accumulation zone, down 7.7 points over five sessions.
67.9Accumulation
Down 7.7 points over five sessions, from the Buying zone.
Reading for Sep 18, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 28 | +0.9% | +3.2% | ||
| Accumulation (current zone) | 187 | −0.1% | 0.0% | ||
| Neutral | 357 | +0.1% | +1.2% | ||
| Distribution | 43 | +0.3% | −1.0% | ||
| Selling | 0 | Not available | |||
Average HLN share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the HLN price, zone by zone.Track HLN in Gekko
Is Haleon stock overvalued? Gekko Fair Value
Haleon trades 30.6% below Gekko Fair Value of $13.37, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Haleon shares are worth, recalculated every trading day.
$13.37
Gekko Fair Value, Sep 19, 2026
30.6% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open HLN in Gekko
Haleon insider and Congress trading
No open-market insider purchases were filed for Haleon, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in HLN were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for HLN, plotted on the chart in Gekko.Open HLN in Gekko
Haleon earnings: next date and track record
Haleon beat the EPS estimate in 3 of its last 8 reports, moving 1.8% on average across the report.
3 of 8reports beat the EPS estimate
±1.8%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Apr 29, 2026 | $0.00 est $0.12 | — | −2.4% |
| Oct 30, 2025 | $0.14 est $0.24 | $7.52B est $2.76B | +2.4% |
| Aug 7, 2025 | $0.08 est $0.24 | $7.25B est $2.76B | +3.1% |
| Jul 31, 2025 | $0.09 est $0.11 | — | +0.2% |
| Apr 30, 2025 | $0.13 est $0.00 | — | +0.5% |
| Feb 27, 2025 | $0.05 est $25.25 | $7.14B est $2.74B | −0.2% |
| Oct 31, 2024 | $0.14 est $0.11 | $6.93B est $11.04B | −0.7% |
| Aug 1, 2024 | $0.10 est $0.09 | — | +5.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Haleon stock forecast and analyst price targets
Analysts’ average 12-month price target for Haleon is $11.99, +29.2% from the last close, from 1 firm rating the stock in the last 90 days.
$11.99consensus 12-month target, +29.2% from the last close
Each firm’s latest rating in the last 90 days: 1 firm.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Aug 6 | Morgan Stanley | $6.20 | −33.2% |
0.0%average 20-day move after past Accumulation readings
+1.1%average move over the next 20 trading days in the last 4 years
±2.1%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Haleon seasonality: the next 20 trading days
Over the next 20 trading days from Sep 19, Haleon averaged +1.1% across the last 4 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −0.2% | 2 of 4 |
| Next 10 trading days | +0.9% | 2 of 4 |
| Next 15 trading days | −0.4% | 2 of 4 |
| Next 20 trading days | +1.1% | 3 of 4 |
| Next 30 trading days | −0.7% | 2 of 4 |
For scale, HLN’s typical 20-trading-day move in either direction is about 4.1%.
Haleon market cap and key statistics
Haleon’s market cap is $40.87B, with a P/E ratio of 19.1 and revenue of $11.15B over the last twelve months.
Valuation
- Market cap
- $40.87B
- P/E ratio
- 19.1
- Forward P/E
- 15.5
- EPS, TTM
- $0.49
- Gekko Fair Value
- $13.37
Trading
- Volume
- 45.17M
- Avg volume, 20 days
- 15.06M
- 52-week high
- $11.28
- 52-week low
- $8.65
- Shares outstanding
- 4.40B
Financials
- Revenue, TTM
- $11.15B
- Profit margin
- 14.5%
- Return on equity
- 10.1%
- Quarterly earnings growth, YoY
- −4.5%
Risk and income
- Beta
- 0.25
- Typical daily move
- ±2.1%
- Typical 20-day move
- ±4.1%
- Dividend yield
- 2.12%
Haleon stock news this week
Coverage of Haleon this week reads positive: 2 positive, 1 neutral and 1 negative headlines.
- Alan Stewart Acquires 242 Haleon Shares at A33.378619 Through Dividend ReinvestmentKalkine Media, Sep 18
- Advil-maker Haleon boosts US sales by targeting consumers on weight-loss drugsReuters, Sep 16
- What Does Haleon's (LSE:HLN) Interim Dividend Tell Us About Life After The GSK Spin-Off?Kalkine Media, Sep 15
- LCUT or HLN: Which Is the Better Value Stock Right Now?Zacks Investment Research, Sep 11
- Avoiding Lag: Real-Time Signals in (HLN) MovementStock Traders Daily, Sep 11
Haleon stock FAQ
What is Haleon’s market cap?
Haleon’s market cap is $40.87B at the Sep 18, 2026 close of $9.28, with 4.40B shares outstanding. The shares trade on a P/E ratio of 19.1.
What is the Haleon stock forecast?
The consensus analyst 12-month price target for Haleon is $11.99, +29.2% from the last close. Of the 1 firm that rated the stock in the last 90 days, 1 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Haleon stock overvalued or undervalued?
On Gekko’s estimate Haleon is undervalued: the Sep 18, 2026 close of $9.28 is 30.6% below Gekko Fair Value of $13.37. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
What is Haleon’s 52-week high and low?
Haleon’s 52-week high is $11.28 and its 52-week low is $8.65; it closed at $9.28 on Sep 18, 2026, −1.3% over the past year.
Is Haleon stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 4 items with data read as supportive (gekkoindex, fair value and seasonality) and 1 as a headwind (trend). The checklist is a description of current data, not a recommendation.
How this page works
Prices and signals update after every US market close; the GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Haleon the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,349 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.